Cefepime NEW
| Price | $32 | $40 | $59 |
| Package | 25mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Cefepime | CAS No.: 88040-23-7 |
| Purity: 98.73% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Cefepime |
| Description | Cefepime (BMY-28142) is a cephalosporin antibiotic with antimicrobial activity, induces neurotoxicity, inhibits both Gram-positive and Gram-negative, and can be used in the study of anaerobic bacteria. |
| In vivo | METHODS: Mice were given different doses of cisplatin (0, 10, 14, 18, 22, and 26 mg/kg) three days before intraperitoneal (ip) injection of 80 mg/kg cefepime to determine the dose of cisplatin that would not affect mouse survival and achieve human-like serum concentrations of cefepime. RESULTS: The half-life of cefepime was significantly prolonged at cisplatin doses of 18 and 22 mg/kg. [1] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4 mg/mL (8.32 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (20.81 mM), Solution. DMSO : 250 mg/mL (520.23 mM), Sonication is recommended. H2O : 80 mg/mL (166.47 mM), Sonication is recommended. |
| Keywords | Cefepime | Antibiotic | Antibacterial |
| Inhibitors Related | Neomycin sulfate | Adipic dihydrazide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Doxycycline | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate | Sodium bicarbonate | BES |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Approved Drug Library | Antibiotics Library | Drug Repurposing Compound Library | Beta-Lactam Compound Library | Anti-Bacterial Compound Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Anti-Infection Compound Library | NMPA-Approved Drug Library | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-07-23 | ||
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-07-21 | ||
| $40.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $40.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
|
VIP9Y
|
Guangzhou PI PI BIOTECH INC
|
2025-12-19 | ||
|
VIP3Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2025-04-02 | ||
| $5.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-25 | ||
| $10.00 |
Hebei Zhanyao Biotechnology Co. Ltd
|
2022-01-14 | ||
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-05-25 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY